上海招聘

This position will report directly to the Vice President, preclinical development and translational medicine. This individual will be a part of the translation Medicine team within Hengrui Medicine. 

Key responsibilities

·         In vitro pharmacology leadership providing program support in both Oncology and/or non-Oncology areas;

·         Lead an in-vitro pharmacology team, establish and run in vitro pharmacology studies through internal and external resources. Work on multiple aspects within translation medicine team, including target identification and validation, MoA study, assay development for discover projects and biomarker identification/validation, etc.

·         Ensure high quality data to support decision making on individual compounds and programs and effectively communicate research to executive leadership;

·         Advocate early development strategy, biomarker selection, and combination approaches for new development programs;

·         Effectively collaborate with other functions in the discovery and development organizations.

Qualifications

·         PhD in biological sciences including molecular/cell biology, pharmacology, Immunology, or biochemistry

·         Years of experience in an academic and/or industry settings; Expertise in in vitro pharmacology, leading drug discovery projects with track records.

·         Experience in managing/leading external collaborations with academic and industry partners.

  

   上海恒瑞医药有限公司成立于2001年，注册资本7200万，系江苏恒瑞医药有限公司的全资子公司。公司位于上海闵行经济技术开发区内，占地80亩，拥有高水平的科研实验基地和高水准的GMP生产车间。
   公司的经营目标为：采用先进适用技术和科学的经营管理方法，以高新化合物和新剂型的创新研究为依托，兴建先进的研发中心，并建立相应的生产工厂。
   在科研开发方面：公司瞄准国际先进水平，建立科研基础平台，积极拓展新药研发领域，增加产品剂型，参与国内国际市场竞争，提高民族医药工业水平。
   在生产管理方面：公司主要生产和销售大容量吸入剂、喷雾剂及冻干粉针剂。并秉承恒瑞医药"不断提高药品品质，致力人类健康幸福"的宗旨，严格按照GMP组织生产，以优异的产品品质造福社会。
   作为恒瑞医药的对外窗口，上海恒瑞医药有限公司肩负着神圣的使命。为恒瑞医药构筑一个面向国内外的信息交流平台、人才聚集平台、全面与国际接轨的生产经营和研究开发平台，使之成为恒瑞医药的新闪光点、新经济增长点。